Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

History bears witness that wars are decided not merely by power, strategy, and weaponry, but also by the unpredictable nature ...

Very likely not, at least not as long as MAHA embraces quackery and antivax pseudoscience—not that that didn't stop STAT News from ignoring the elephant in the room, vaccines, in sear ...

Opioid dependence, characterized by high relapse rates and substantial social harm, represents a major global public health ...